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 Abstract 
Objectives 
Molecular epidemiology is applied to various aspects of HIV transmission analyses. With 
ultra-deep sequencing (UDS), in-depth characterisation of transmission episodes involving 
minority variants are permitted. We explored HIV-1 epidemiological linkage and evaluated 
characteristics of transmission dynamics and transmitted drug resistance (TDR) detection 
through the added value of UDS. 
Design  
HIV pol gene fragments were sequenced by UDS and Sanger sequencing (SS) on samples 
of 70 HIV-1 infected, treatment-naïve recently diagnosed men having sex with men (MSM). 
Methods 
Pairwise genetic distances and maximum likelihood phylogenies were computed. 
Transmission events were identified as clades with branch support ≥70% and intra-clade 
genetic difference <4.5%. TDR mutations were recognised from the TDR consensus list. 
Transmission directionality, directness and inoculum size were inferred from tree topologies. 
Results 
Both datasets concurred in the identification of 7 transmission pairs and 1 cluster of 3 
patients. With UDS, direction of transmission was inferred in 4/8 chains. Evidence for 
multiple founder viruses was found in 2/8 chains. No transmission of minority resistant 
variants was evidenced. TDR mutations prevalence in protease and reverse transcriptase 
fragments was 4.3% with SS and 18.6% with UDS. 
Conclusions 
While SS and UDS identified the same transmission chains, UDS provided additional 
information on founder viruses, direction of transmission and levels of TDR. Nevertheless, 
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 topology of clusters was not always consistent across gene fragments, calling for a cautious 
interpretation of the data. Moreover, unobserved intermediary links cannot be excluded. 
Phylogenetic analysis use as a forensic technique for HIV transmission investigations is 
risky. 
 
Keywords: HIV-1; HIV infection; Phylogeny; Cluster analysis; Homosexuality, Male; Drug 
Resistance, Viral; High-Throughput Nucleotide Sequencing; Minority resistant variants. 
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 Introduction 
Molecular epidemiology is a powerful approach applied to various aspects of HIV 
transmission analyses, such as the characterisation of patterns of infection within risk or 
ethnic groups [1–4], the study of transmitted antiretroviral resistance [5–7], the quantification 
of misreported routes of infection [8,9] or, most recently, the assessment of treatment 
strategies efficiency in intervention-based trials [10]. This approach implies the phylogenetic 
identification of viral isolates more genetically similar to each other than expected by chance 
in an infected population, thus establishing epidemiological linkage between individuals the 
related viruses are sampled from.  
HIV molecular epidemiology predominantly relies on ‘convenience’ data routinely generated 
for antiretroviral resistance monitoring, where consensus HIV pol sequences are generated 
by PCR-based Sanger sequencing (SS) prior to treatment initiation [11]. Although this 
genetic fragment contains sufficient phylogenetic signal to identify transmission clusters [12], 
it has the shortcomings of a consensus sequence. It does not reflect intra-host genetic 
diversity of the HIV population, precluding in-depths analyses of the role of minority variants 
at transmission. It is also notoriously challenging to infer direction of transmission from 
consensus sequence data, unless sophisticated statistical inference is applied [13,14]. 
Finally, the incomplete sampling of cases inherent to this data substantially limits attempts to 
infer directness of transmission within a phylogenetic pair or cluster, as the possibility of 
unobserved intermediate transmissions is difficult to exclude when individuals are 
represented by a single viral sequence.  
The development of ultra-deep sequencing platforms (UDS) has imposed new data 
standards. While SS detects viruses accounting for more than 15-20% of the infecting 
population, UDS technologies permits the detection of minority variants representing <1% of 
the viral population. The sensitivity and depth of UDS has therefore the potential to unravel 
transmission episodes involving variants existing at low frequency [15]. Direction of 
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 transmission is also likely to be inferable from the information contained within UDS data, 
where the viral population of the recipient is expected to be nested within that of the 
transmitter [16]. Most recently, novel analytical tools were developed to that effect [17,18]. 
UDS also provides valuable insight into transmitted drug resistance (TDR). Through its 
increased sensitivity, UDS allows the detection of HIV-1 minority resistant variants (MRV), 
which may be a cause of virological failure when transmitted, as shown for first line regimens 
based on first generation NNRTIs [19–21]. Understanding the frequency and dynamics of 
MRV transmission is therefore of the upmost importance and UDS data provides invaluable 
information on the matter.  
We conducted a phylogenetic transmission study using HIV pol gene sequences sampled 
from men who have sex with men (MSM). We compared the clustering pattern of sequences 
generated by SS and UDS, and assessed the ability of the latter to unravel epidemiological 
features such as direction and directness of infection, multiplicity of founder viruses and 
frequency of minority resistant variants transmission.  
Methods 
Study cohort. The study enrolled 70 treatment-naïve, HIV-positive MSM diagnosed between 
January 2012 and July 2013. Patients were followed at the Department of Infectious 
Diseases of the hospital Pitié-Salpêtrière (Paris, France). Clinical information was extracted 
from the hospital electronic database or medical records and was anonymised prior to 
analysis. This information included age of the participant, time of HIV diagnosis, time of 
blood sampling, time of last negative HIV test (when applicable), estimated time of infection 
(as reported by the patient), viral load and CD4+ T cell count at sampling. All subjects have 
signed the ethics board-approved informed consent form of the HIV Nadis® electronic 
patient record database. 
Immunoassay testing. In order to identify recently HIV-1 infected patients (≤ 6 months), a 
single, indirect enzyme-linked immunosorbent assay was used to quantify antibodies 
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 directed against two HIV-1 antigens (i.e. consensus peptides of the immunodominant 
epitope of gp41 and consensus V3 peptides), as described previously [22]. 
Viral gene sequencing and sequence data. HIV pol gene fragments were sequenced from 
the first HIV-positive plasma sample available for each patient, using both (i) SS and (ii) 
UDS. 
(i) SS: full length protease (PR; 297bp; HXB2 position 2253 - 2549) and partial reverse 
transcriptase (RT; 771bp; position 2550 - 3320) consensus sequences were obtained, 
according to the routine Agence Nationale de Recherche sur le Sida et les hépatites virales 
(ANRS) protocol [23]. Sequences found to have a mixture of wild type and mutant residues 
at a given codon position were considered to have the mutant residue at that position. 
Subtype determination was performed using the BLAST-based SmartGene HIV Module 
(SmartGene, Zug, Switzerland).  
(ii) UDS: Steps until pyrosequencing on GS Junior (Roche 454® Life Sciences, Branford, 
CT, United States) were previously described [24]. Primers are available on 
hiv.frenchresistance.org. Pyrosequencing was performed according to the manufacturer 
recommendations [25]. Due to the length of the gene, reverse transcriptase pyrosequencing 
was performed in 2 fragments: first fragment RT1 (HXB2 RT amino acid position 17-140), 
second fragment RT2 (HXB2 RT amino acid position 133-247). GS Amplicon Variant 
Analyzer (Roche 454® Life Sciences, Branford, CT, United States) was used to analyze the 
UDS results.  
Drug resistance mutation identification. TDR mutations were identified from the 2009 
restrictive consensus list for surveillance of transmitted HIV-1 drug resistance [26]. 
Resistance-associated mutations were also identified using the ANRS algorithm V27 
(http://www.hivfrenchresistance.org), which considers more mutations than the TDR 
consensus list.  
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 Transmission cluster identification. Putative transmission events between the studied 
patients were identified by phylogenetic means, using UDS data, for each gene fragment 
(i.e. PR, RT1 and RT2). Intra-host variant sequences were manually aligned using AliView 
v.1.18 [27] after removal of duplicates. A maximum likelihood (ML) tree was reconstructed 
under the general time reversible model of nucleotide substitution with gamma-distributed 
rate heterogeneity (GTR+G), using FastTree v1.2.7 [28]. Branch support was estimated 
using the Shimodaira-Hasegawa-like likelihood ratio test (SH-aLRT; [29]) implemented in 
FastTree. Putative transmission clusters were extracted from the PR, RT1 and RT2 
phylogenies with ClusterPicker [30]. The criteria used for cluster identification were (i) ≥ 2 
monophyletic sequences, (ii) a branch support ≥ 0.70 and (iii) a maximum intra-cluster 
pairwise genetic distance inferior to a given threshold. Distance thresholds of 1.5%, 2.0%, 
2.5%, 3%, 3.5% and 4.5% nucleotide differences were used. Gaps were treated as missing 
characters. Patients for which viral sequences clustered in all phylogenies (PR, RT1 and 
RT2) were considered as epidemiologically linked. 
Putative transmission clusters were also identified from the SS phylogenies using the same 
criteria as those applied to the UDS data, for each gene fragment (i.e. PR and RT), as a 
point of comparison. Publically available control sequences were extracted from GenBank by 
BLAST search [31], retaining the 10 closest matches to each patient sequence. Additional 
control sequences from local HIV positive individuals (n = 29) were also added to the 
dataset. After removal of duplicates, alignments of 643 (PR) and 370 (RT) sequences were 
manually generated using the sequence editor AliView v.1.18. ML trees were reconstructed 
using FastTree under the GTR+G model.  
Each procedure was repeated after removing codon positions associated with major 
antiretroviral resistance [26] from the original alignments, in order to check the effect of 
treatment-induced convergent evolution. 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 Pairwise genetic distances calculations. Intra-cluster pairwise nucleotide differences were 
calculated for each transmission cluster using the package HyPhy v2.1.2 [32], under the 
TN93 model of evolution (determined as the best fitting model with the model testing 
algorithm included in HyPhy), for both SS and UDS sequence data.  
Inference of directionality and directness of transmission. Directionality (i.e. 
transmitter/recipient relationship, or ‘who infected whom’) and directness (i.e. no evidence of 
an unobserved intermediate transmitter) of transmission were inferred within each UDS 
cluster as follows. 
First, the phylogeny of each individual cluster was rebuilt and rooted against an outgroup 
formed of sequences from the two patients most closely related to the cluster of interest in 
the initial ML phylogenies. Direction of transmission between the linked individuals was then 
inferred from the topological structure of the UDS clusters and the cladistics relationship 
between the two sequenced populations within them, as formulated by Romero-Severson et 
al. [16]. When both viral populations were monophyletic within a cluster (monophyletic-
monophyletic topology, MM; Figure 1A), the direction of infection was deemed as equivocal. 
When one population was paraphyletic and the other monophyletic (paraphyletic-
monophyletic topology, PM; Figure 1B), the paraphyletic population was assigned to the 
transmitter. When both populations were paraphyletic (paraphyletic-paraphyletic topology, 
PP; Figures 1C & D), the population whose most recent common ancestor was closest to 
the ancestral node of the clade was assigned to the transmitter. Directionality was validated 
and considered unequivocal when the same direction of transmission was observed in all 
UDS genetic fragments (i.e. PR, RT1 and RT2). 
Directness of transmission was inferred for clusters exhibiting a PP topology only (Figures 
1C & D), under the assumption that intermixing of transmitter and recipient viral populations 
is indicative of a recent and direct transmission event. MM and PM clusters were deemed 
equivocal to that respect (Figures 1A & B).  
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 Multiplicity of the recipient’s founder viruses. For each direct transmission pair, the size of 
the inoculum was inferred from the topology of the recipient’s clade(s) in the tree. In PP 
clusters, the inoculum was assumed to derive from more than one virus and the minimum 
number of founding strains was calculated as the number of internal nodes linking viral 
sequences from both the transmitter and recipient (Figures 1C & D). In PM and MM 
clusters, the size of the inoculum was deemed equivocal since directness of transmission 
could not be established with certainty (Figures 1A & B).  
Results 
Patients and virus’ characteristics. The median age of the participants was 36 years (range 
22-65). Median viral load at sampling was 4.9 log10 HIV RNA copies/mL (IQR=4.4-5.4) and 
median CD4 cell count was 498/mm3 (IQR=347-585). The median time between the HIV-1 
diagnosis and date of the sample used for genotyping was 11 days (IQR: 2.25-29). No 
multiple HIV infection was detected in the patients. Antibodies quantification was performed 
on 69/70 serum samples and identified 28 recently HIV-1 infected individuals (infection ≤ 6 
months prior to diagnosis). A total of 42/70 patients (60%) were infected by HIV-1 subtype B. 
Non-B infections included CRF02_AG (15 patients; 21%), subtype C (4 patients; 6%), 
subtype F2 (3 patients; 4%), subtype F1 (2 patients; 3%), CRF01_AE (2 patients; 3%) and 
CRF07_BC (2 patients; 3%). 
Ultra-deep sequencing. An average of 2,633 reads per nucleotide position was amplified. 
The average error rates in controls (cellular clone 8E5) were 0.0032 and 0.0012 
substitutions per base for PR and RT, respectively, allowing an accurate detection of 
variants down to 1% [33]. 
Transmission clusters identification. The putative transmission clusters identified with UDS 
data, by genetic fragment, are shown in Table 1 and Supplementary Figure 1, 
http://links.lww.com/QAD/B408. A total of 38 patients (forming 19 clusters) were linked on the 
basis of at least one gene fragment. However only 8 clusters, 7 pairs and one triplet, were 
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 identified by phylogenetic clustering of all tested fragments (highlighted in bold in Table 1). 
These 8 clusters were also consistently identified within the SS phylogenies and remained 
intact after exclusion of drug resistance associated mutations, rejecting the hypothesis of 
clustering artefacts derived from treatment-induced convergent evolution (data not shown).   
These 8 clusters were deemed to represent genuine transmission chains and were included 
in the subsequent analyses. The subtype of the clustered sequences was B (3/8), C (2/8), 
CRF_AG (2/8) and CRF07_BC (1/8). Two of the eight transmission clusters contained 
sequences from the background controls in the SS PR phylogenies (clusters [31,70] and [52, 
60] and in the SS RT phylogenies (cluster [31,70]). For cluster [31/70], the origin of the 
interspersed control sequence matched the country of origin of the patients, adding further 
credit to the linkage. Sampling interval within the putative transmission clusters ranged from 
0 to 355 days (median: 165 days; Table 1).  
Intra-cluster pairwise genetic distances. As expected, UDS intra-cluster pairwise genetic 
distances in PR and RT were higher than SS pairwise distances (Supplementary Figure 2, 
http://links.lww.com/QAD/B408). However, none of the maximum UDS pairwise distances for 
a given cluster exceeded 4.5% nucleotide differences.  
Directionality, directness and inoculum size inference. An example of the different topologies 
(i.e. MM, PM or PP) observed amongst the UDS transmission clusters is shown in Figure 2. 
Cluster topologies were coherent across all fragments for 4/8 putative transmission clusters, 
being either PP (clusters [05,41] and [19,62]), PM (clusters [31,62]) or MM (cluster [52,60]) 
(highlighted in grey Table 2). Three clusters had a PP and PM topology in PR and RT 
respectively ([08,44], [17,30] and [34,46]). The last cluster included three patients, resulting 
in more complex clustering patterns (see below). In all PM trees, the branch leading to the 
monophyletic recipient population was deemed robust, with branch supports ranging from 
78% to 100%. No correlation between the clusters’ topology and sampling interval between 
the transmitter/recipient viral populations was observed (data not shown).  
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 Direction of transmission could be inferred in 4/8 clusters (50%; clusters [5,41], [8,44], 
[17,30] and [31,70]; Table 2). In those clusters, the topology was consistent across all 
fragments. Clusters for which direction was equivocal included a cluster consistently 
exhibiting a MM topology (cluster [52,60]) or those for which differences in tree topology 
suggested conflicting scenarios (clusters [19,62] and [34,46]). Direction of transmission 
could be partially inferred within cluster [25, 33, 45], which comprised three linked 
individuals. In this cluster, the viral sequences derived from patient 45 were paraphyletic and 
basal to the cluster in all phylogenies. Sequences from patients 25 and 33 formed distinct 
sub-clusters, either monophyletic or paraphyletic, branching off the patient 45’s viral 
population (Supplementary Figure 1, http://links.lww.com/QAD/B408). These patterns 
suggest that patient 45 may be at the origin of patients 25 and 33’s infections, but whether 
the latter were independently infected by 45 or infected each other remains unclear. In 
addition, immunoassay and sample collection dates confirmed that patient 33 was infected 
later than patient 45, giving credence to phylogeny results. 
Directness of transmission and multiplicity of the founder viruses could be inferred in two 
clusters only, i.e. clusters exhibiting a PP topology in all fragments (pairs [05,41] and [19,62]; 
Table 2). The observed number of founder viruses varied across genetic fragments for a 
same cluster, ranging from 2 (in RT2) to 8 (in RT1) for cluster [05,41], and from 3 (in RT2) 
and 10 (in RT1) for cluster [19,62] (Supplementary Figure 1, 
http://links.lww.com/QAD/B408).  
Transmitted drug resistance. The overall prevalence of TDR mutations in the PR and RT 
fragments was 4.3% (3/70; 95%CI=0.0%-9.1%) with SS and 18.6% (13/70; 55%CI=9.4%-
27.7%) with UDS. Total concordance was found between the two sequencing methods for 
mutations detected at a frequency >20% with UDS. Although no TDR mutation was detected 
in the 17 patients involved in transmission chains by SS, UDS detected TDR mutations in 
35.3% of them (n=6; 95%CI=12.6%-58.0%). These mutations were present at low 
frequencies (1.1 to 7.0%) and none of shared within a transmission cluster (Table 3). Even 
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 the substitution M46I in PR, detected in patient 45 at a frequency of 7%, was not observed in 
the plasma of the recently HIV-1 infected patient 33. 
When using the ANRS algorithm, polymorphisms to protease inhibitors were found in all 
transmission chains, on both SS and UDS data. Up to 81.8% (27/33) of the polymorphisms 
had reached fixation (i.e. were present in all UDS variants in a given individual) and were 
present in all partners of a given transmission chain (Table 3).  
Discussion 
The reconstruction of transmission chains is the bedrock on which many epidemiological 
interventions are built. For this reason, considerable efforts are invested in the generation of 
deep sequencing viral data from infected populations, together with the development of 
phylogenetic frameworks to analyse them [17][34–36]. UDS data provides a snapshot of 
intra-host viral diversity to unprecedented levels, and we show that such information 
significantly improves the resolution of HIV transmission studies compared to routinely 
generated HIV sequencing.  
Parallel analyses of SS and UDS data derived from the same primary samples concurred 
remarkably well in the identification of HIV transmission chains in our study. Good 
correspondence between maximal pairwise genetic distances was observed with SS and 
UDS, indicating that distance-based clustering approaches traditionally applied to SS 
sequence data are applicable to UDS-derived phylogenies while capturing the underlying 
genetic diversity of minority variants. This also suggests that no minority variant, present at < 
20%, the sensitivity limit of SS, was transmitted in the studied cohort. This is in line with the 
fact that no drug resistant minority variant was transmitted.  
Direction of transmission is notoriously difficult to infer in HIV infections. Traditional 
approaches for inferring a pathogen’s direction of transmission rely on known times of 
infection or time of symptom onset. This is due to the complex within-host evolution 
dynamics of the viral population, the chronic nature of an HIV infection, and the frequent lack 
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 of epidemiological or clinical information from which a plausible window of transmission can 
be established. We used the topological structure of phylogenetic clusters to infer 
directionality in the studied transmission pairs. Our results confirmed the predictions of 
Romero-Severson’s model [16], both in its advantages and limitations. Indeed, directionality 
remained equivocal in the transmission pairs we identified when the viral populations 
sampled from the linked individuals both exhibited a monophyletic structure. The same 
limitations applied to estimating the likelihood of direct transmissions within the clusters. Due 
to partial sampling of the infected population, the possibility of an intermediate transmitter 
between sampled linked individual cannot be excluded with certainty. As already raised by 
Abecasis and al., this point is critical, and the phylogenetic analysis use as a forensic 
technique for HIV transmission investigations is risky [37]. 
The weakness of the phylogenetic signal in the selected genetic fragments represented a 
significant limitation of this study. It resulted in phylogenetic uncertainty, topological 
discrepancies across fragments and sometimes in conflicting results from one region to 
another (see cluster [34/46], where the topology of the cluster identified patient 34 as the 
transmitter in PR and 46 in RT). The HIV pol gene exhibits high levels of conservation, due 
to strong purifying selection. Although routine genotyping fragments were shown to contain 
enough patient-specific diversity to establish epidemiological linkage [12], the short 
fragments yielded by the 454 sequencing technology aggravated the phylogenetic signal of 
the data. Even shorter fragments, such as those obtained with the popular Illumina 
platforms, may represent a more severe challenge with the phylogenetic reconstruction 
method used until further technological improvements are reached. A trade-off between 
length and multiplicity of the sequences must therefore be reached.  
The topology and branch uncertainty observed in most phylogenies precluded a precise 
estimation of the minimum number of transmitted founder variants in most cases. This was 
emphasized by the fact that topological structure varied across genetic fragments in 4 of the 
8 transmission chains identified, and most likely due to differences in phylogenetic signal 
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 and variant sampling bias across genes. However, when multiple, the minimum number of 
founder variants initiating infection was estimated to range between 2 and 10, depending on 
the genetic fragment. These estimates are in agreement with studies conducted in 
individuals with acute or very recent HIV infections [38] and support the notion of a massive 
reduction of genetic diversity at transmission. Through multiple bottlenecks, both stochastic 
and selective, the large, genetic diverse population found in a transmitter is reduced to a 
remarkably small number of established lineages in the recipient. This reduction is believed 
to be down to a single variant in a majority of sexual transmissions [39], but our framework 
did not allow us to observe such pattern. Monophyletic populations in the recipient could 
indeed have explanations other than a single founder virus, such as the presence of an 
observed intermediate host. 
While majority resistant variants were mainly detected among all patients of a cluster, no 
evidence of transmission of MRV was observed in this work, as recently observed by 
Chaillon et al. [40]. This suggests either preferential transmission of majority variants and/or 
minority drug-sensitive variants or post transmission reversion to wild type. Carlson et al. 
found that transmitted viruses are the fittest, moderated by factors such as transmitter viral 
load and recipient genital inflammation [41]. Resistant variants are generally less fit than 
wild-type variants. On the other hand, rapid change of minority variants levels during early 
infection had been reported [42], supporting viral lineage modifications in response to 
adaptive immunity or consistent with the hypothesis that fitness-impacting mutations are 
efficiently and rapidly removed.   
In conclusion, UDS could provide extra information on founder viruses and linkage but the 
interpretation of the data is still hazardous. The use of whole genome sequencing data or 
large fragments to improve the phylogenetic analysis by UDS must be studied. 
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 Figures Legend 
Figure 1. Schematic representation of the possible phylogenetic relationships between two 
viral populations in a transmission cluster and their interpretation (Adapted from Romero-
Severson et al. 2016 [16]). Ancestral nodes are marked with circles and monophyletic 
groups of sequences from a given individual collapsed into triangles. For a putative 
transmission pair involving two individuals X (white) and Y (grey), the phylogenetic cluster 
formed by the two viral populations can exhibit three possible topologies: (A) When both viral 
populations were monophyletic (monophyletic-monophyletic topology, MM), the direction of 
infection was deemed as equivocal; (B) When one population was paraphyletic and the other 
monophyletic (paraphyletic-monophyletic topology, PM) the paraphyletic population was 
assigned to the transmitter (here, X); (C & D) When both populations were paraphyletic 
(paraphyletic-paraphyletic topology, PP), the population inferred to be ancestral to the 
cluster (marked with circles) was assigned to the transmitter. Directness of transmission was 
deemed equivocal for MM and PM topologies (A & B). A single founder virus was assumed 
to be transmitted in PM topologies (B), while PP topologies were considered representative 
of the transmission of multiple founder viruses (C & D).  
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 Figure 2. Examples of monophyletic-monophyletic (A), paraphyletic-monophyletic (B) and 
paraphyletic-paraphyletic (C) topologies observed amongst three putative transmission 
pairs. Sequences from the inferred transmitters (patients 52, 17 and 19) and recipient 
(patients 60, 30 and 62) are coloured in black and red, respectively.  
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 Table 1. Putative transmission clusters identified by phylogenetic reconstruction 
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 Table 2. Inferred direction and directness of transmission within transmission clusters 
Cluster PR RT1 RT2 
Topology1 Direction Directness Topology1 Direction Directness Topology1 Direction Directness 
[05, 41] PP 05 > 41 Direct PP 05 > 41 Direct PP 05 > 41 Direct 
[08, 44] PP 08 > 44 Direct PM 08 > 44 Equivocal PM 08 > 44 Equivocal 
[17, 30] PP 30 > 17 Direct PM 30 > 17 Equivocal PM 30 > 17 Equivocal 
[19, 62] PP 62 > 19 Direct PP 62 > 19 Direct PP 19 > 62 Direct 
[25, 33, 
45] MPP 45 > 25/33 Equivocal MMP 45 > 25/33 Direct MPP 45 > 25/33 Equivocal 
[31, 70] PM 70 > 31 Equivocal PM 70 > 31 Equivocal PM 70 > 31 Equivocal 
[34, 46] PP 34 > 46 Direct PM 46 > 34 Equivocal PM 46 > 34 Equivocal 
[52, 60] MM Equivocal Equivocal MM Equivocal Equivocal MM Equivocal Equivocal 
1 MM, monophyletic/monophyletic; PM, paraphyletic/monophyletic; PP, paraphyletic/paraphyletic 
Cluster topologies coherent across all fragments are shown in grey. 
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 Table 3. Drug resistance mutations in the putative transmission clusters. 
Cluster 
Patien
t 
Inferred 
direction 
Recentl
y  
infecte
d 
TDR (from Bennet et al. 
2009) 
DRMs (ANRS algorythm) 
 
PR RT PR RT 
[05, 41] 5 
Transmit
ter 
No - 181C (1.1%) 60E, 63P 
181C 
(1.1%) 
  41 
Recipien
t 
Yes - 188H (1.1%) 60E, 63P 
188H 
(1.1%) 
[08, 44] 8 
Transmit
ter 
No 
84V 
(1.7%) 
- 10I, 15V, 69K, 84V (1.7%), 89I - 
  44 
Recipien
t 
No - - 10I, 15V, 69K, 89I - 
[17, 30] 17 
Recipien
t 
Yes - - 62V - 
  30 
Transmit
ter 
Yes - - 62V - 
[19, 62] 19 N/A No - - 15V, 36I, 69K, 89M - 
  62 N/A No - - 
15V, 36I, 62V (2.8%), 69K, 
89M 
- 
 
[25, 33, 
45] 
25 N/A Yes - - 20I, 36I, 63P, 69K, 89M - 
  33 N/A No - - 20I, 36I, 63P, 69K, 89M - 
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   45 
Transmit
ter 
No 
46I 
(7.0%) 
- 
20I, 36I, 46I (7.0%), 63P, 69K, 
89M 
- 
[31, 70] 31 
Recipien
t 
No - - 33V (7.6%), 60E, 63P - 
  70 
Transmit
ter 
No - 
 
15V (12.0%), 60E, 62V,  63P, 
77I 
101R 
[34, 46] 34 N/A Yes - - 16E, 20I, 36I, 69K, 89M - 
  46 N/A Yes - - 16E, 20I, 36I, 69K, 89M - 
[52, 60] 52 N/A No - 219N (1.1%) 63P, 71T - 
  60 N/A Yes 
 82A 
(3.0%) 
- 63P, 71T, 82A (3.0%) - 
 
Mutations detected by both UDS and SS are underlined. The frequency of minority resistant variants detected by UDS is 
indicated in brackets. 
DRMs: drug resistance mutations; IN: integrase; PR: protease; RT: reverse transcriptase; SS: Sanger sequencing; TDR: 
transmitted drug resistance; UDS: ultra-deep sequencing. 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
